J&J ‘very confident’ in vaccine, eyes quick resolution

Johnson & Johnson remains “very confident” in its Covid-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.